Nasus Pharma
Price & Volume
Stats
See more52W Range | $0-$9.99 |
Market Cap | $31.2M |
Shares Short | 8,874 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.21 |
News
See moreYahoo Finance • 6 days ago
BriefCast Publishes Transcript: Nasus Pharma NS002 Phase 2 Positive Topline Results Webinar Transcript
Yahoo Finance • 9 days ago
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
Yahoo Finance • 12 days ago
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Yahoo Finance • last month
Nasus Pharma to Participate in Upcoming Investor Conferences
About
CEO | Mr. Dan Teleman MBA M.Sc. |
CFO | Mr. Eyal Rubin M.B.A. |
Address | Yigal Alon 65, Tel Aviv-Yafo, Israel, 6744317 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 1 |
